This Experimental Treatment Cut Cholesterol by 62 Percent—With No Statins
RSS SUMMARY · AGGREGATED FROM INC
A study published in the New England Journal of Medicine revealed a new therapy that can cut “bad” cholesterol by 62 percent with one dose. Could it replace lifelong statin use?
A study published in the New England Journal of Medicine revealed a new therapy that can cut “bad” cholesterol by 62 percent with one dose. Could it replace lifelong statin use?
A study published in the New England Journal of Medicine revealed a new therapy that can cut “bad” cholesterol by 62 percent with one dose. Could it replace lifelong statin use?
Continue Reading
The full story continues on Inc..
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
INC
Business
Ronny Chieng Told Harvard Grads to ‘Destroy AI.’ They Cheered
INC·1h ago·3 min read
Business
Panera Bread Store Closures: See a List of Shuttered Locations as the Fast-Casual Chain Charts 2026 Growth
INC·2h ago·3 min read
Business
Stanley’s Viral Quencher Made It Famous. Now It’s Trying to Reinvent Itself
INC·2h ago·3 min read
Business
Kane Footwear Is Growing Fast. One Simple Design Choice Is Powering Its Recovery Shoe Success
INC·3h ago·3 min read
Related
On this beat
Business
Goldman Sachs sends urgent warning to stock investors
THE STREET·49m ago·3 min read
Business
Michael Burry drops rare technical warning on Palantir stock
THE STREET·49m ago·3 min read
Business
Luxury chain closes flagship store after 112 years
THE STREET·19m ago·3 min read
Business
Commodities Trader Trafigura Warns of Tipping Point in Energy Markets
TWSJ·59m ago·3 min read